New emtricitabine and pyrimidine-based azetidinone compounds for treating cancer such as breast cancer, lung cancer, and colon cancer
	KAMBLE D; SHANKARANTTI P; KALE M; AGARWAL B; SHELKE P
	2024-12-11
专利权人	SINGH A P (SING-Individual)
申请日期	2024-12-11
专利号	IN202411097675-A
成果简介	NOVELTY - Emtricitabine and pyrimidine-based azetidinone compounds are new. USE - Emtricitabine and pyrimidine-based azetidinone compounds for treating cancer such as breast cancer, lung cancer, and colon cancer (claimed), and leukemia. No biological data given. ADVANTAGE - The emtricitabine and pyrimidine-based azetidinone compound ensures improved therapeutic efficacy and minimal toxicity. DETAILED DESCRIPTION - An INDEPENDENT CLAIM is included for a method for preparing emtricitabine and pyrimidine-based azetidinone compounds.
IPC 分类号	A61K-031/397 ; A61K-031/505 ; A61P-035/00 ; C07D-205/02 ; C07D-239/02
国家	印度
专业领域	医药卫生
语种	英语
成果类型	专利
文献类型	科技成果
条目标识符	http://119.78.100.226:8889/handle/3KE4DYBR/14156
专题	中国科学院新疆生态与地理研究所
作者单位	SINGH A P (SING-Individual)
推荐引用方式 GB/T 7714	KAMBLE D,SHANKARANTTI P,KALE M,et al. New emtricitabine and pyrimidine-based azetidinone compounds for treating cancer such as breast cancer, lung cancer, and colon cancer. IN202411097675-A[P]. 2024.

条目包含的文件
条目无相关文件。

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。